CSK antibody
Principal name
CSK antibody
Alternative names for CSK antibody
Tyrosine-protein kinase CSK, C-SRC kinase, Protein-tyrosine kinase CYL
Ncbi ID
NP_001120662.1, 9606, NP_004374, NP_001120662, NM_004383, NP_004374.1, NM_001030039, NM_001127190
Available reactivities
Available hosts
Available applications
Immunocytochemistry/Immunofluorescence (ICC/IF), Immunoprecipitation (IP), Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Paraffin Sections (P), ELISA (detection) (E(detection)), Flow Cytometry (F)
Background of CSK antibody
- Kit Component:
- - KN210758G1, CSK gRNA vector 1 in pCas-Guide vector
- KN210758G2, CSK gRNA vector 2 in pCas-Guide vector
- KN210758D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
1. Sabe H, Okada M, Nakagawa H, Hanafusa H: Activation of c-Src in cells bearing v-Crk and its suppression by Csk. Mol Cell Biol. 1992 Oct;12(10):4706-13.
2. Chow LM, Fournel M, Davidson D, Veillette A: Negative regulation of T-cell receptor signalling by tyrosine protein kinase p50csk. Nature. 1993 Sep 9;365(6442):156-60.
3. Bergman M, Joukov V, Virtanen I, Alitalo K: Overexpressed Csk tyrosine kinase is localized in focal adhesions, causes reorganization of alpha v beta 5 integrin, and interferes with HeLa cell spreading. Mol Cell Biol. 1995 Feb;15(2):711-22.
4. Takayama Y, Tanaka S, Nagai K, Okada M: Adenovirus-mediated overexpression of C-terminal Src kinase (Csk) in type I astrocytes interferes with cell spreading and attachment to fibronectin. Correlation with tyrosine phosphorylations of paxillin and FAK. J Biol Chem. 1999 Jan 22;274(4):2291-7.
5. Ingley E: Src family kinases: regulation of their activities, levels and identification of new pathways. Biochim Biophys Acta. 2008 Jan;1784(1):56-65.
6. Liang F, Luo Y, Dong Y, Walls CD, Liang J, Jiang HY, Sanford JR, Wek RC, Zhang ZY: Translational Control of C-terminal Src Kinase (Csk) Expression by PRL3 Phosphatase. J
Biol Chem. 2008 Apr 18;283(16):10339-46.


















Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA302657 | CSK (C-term) antibody |
||||||
| Goat Polyclonal Antibody against CSK | |||||||
![]() |
Goat | Aff - Purified | Bov, Can, Hu, Ms, Rt | E, P, WB |
0.1 mg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA312151 | CSK antibody |
||||||
| Rabbit polyclonal anti-CSK antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, ICC/IF, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
+1 additional image |
|||||||
| TA346925 | CSK antibody |
||||||
| Mouse Monoclonal CSK Antibody | |||||||
![]() |
Mouse | IgG2b | 2B4-C6-A10 | Purified | ICC/IF, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AM06531SU-N | CSK antibody |
||||||
![]() |
Mouse | IgG1 | 5F3 | Ascites | Hu, Mky, Ms, Rt | E, F, ICC/IF, WB |
0.1 ml /
€380.00
|
| OriGene Technologies GmbH | |||||||
+2 additional images |
|||||||
| AP20298PU-N | CSK antibody |
||||||
![]() |
Rabbit | Aff - Purified | Hu, Ms, Rt | P, WB |
0.1 mg /
€370.00
|
||
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
| AP20417PU-N | CSK antibody |
||||||
![]() |
Rabbit | Aff - Purified | Hu, Ms, Rt | P, WB |
0.1 mg /
€370.00
|
||
| OriGene Technologies GmbH | |||||||
| SM3138P | CSK antibody |
||||||
![]() |
Mouse | IgG1 | CSK-04 | Purified | Hu, Ms | ICC/IF, IP, WB |
0.1 ml /
€260.00
|
| OriGene Technologies GmbH | |||||||
| SP1415P | CSK antibody |
||||||
![]() |
Goat | Purified | Hu, Ms | WB |
0.1 mg /
€740.00
|
||
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP310758 | CSK (transcript variant 1) |
||||
| Recombinant protein of human c-src tyrosine kinase (CSK), transcript variant 1 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
+1 additional image |
|||||
| TP325740 | CSK (transcript variant 2) |
||||
| Recombinant protein of human c-src tyrosine kinase (CSK), transcript variant 2 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR202254L2V | Lenti ORF particles, Csk (GFP-tagged ORF) - Rat c-src tyrosine kinase (Csk), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,110.00
|
|
| OriGene Technologies, Inc. | ||
| RR202254L1V | Lenti ORF particles, Csk (Myc-DDK-tagged ORF) - Rat c-src tyrosine kinase (Csk), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,000.00
|
|
| OriGene Technologies, Inc. | ||
















+1 additional image





